- Home
- KALU vs OPK Comparison
KALU vs OPK Comparison
Compare KALU & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALU
- OPK
- Stock Information
- Founded
- KALU 1946
- OPK 2007
- Country
- KALU United States
- OPK United States
- Employees
- KALU N/A
- OPK N/A
- Industry
- KALU Metal Fabrications
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- KALU Industrials
- OPK Health Care
- Exchange
- KALU Nasdaq
- OPK Nasdaq
- Market Cap
- KALU 1.4B
- OPK 1.0B
- IPO Year
- KALU 1991
- OPK 1995
- Fundamental
- Price
- KALU $77.36
- OPK $1.38
- Analyst Decision
- KALU Buy
- OPK Buy
- Analyst Count
- KALU 3
- OPK 4
- Target Price
- KALU $78.00
- OPK $2.75
- AVG Volume (30 Days)
- KALU 78.6K
- OPK 1.9M
- Earning Date
- KALU 10-22-2025
- OPK 11-06-2025
- Dividend Yield
- KALU 3.98%
- OPK N/A
- EPS Growth
- KALU 8.08
- OPK N/A
- EPS
- KALU 3.33
- OPK N/A
- Revenue
- KALU $3,113,600,000.00
- OPK $664,029,000.00
- Revenue This Year
- KALU $13.96
- OPK N/A
- Revenue Next Year
- KALU $11.52
- OPK $0.84
- P/E Ratio
- KALU $23.23
- OPK N/A
- Revenue Growth
- KALU 4.62
- OPK N/A
- 52 Week Low
- KALU $46.81
- OPK $1.11
- 52 Week High
- KALU $97.00
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- KALU 50.77
- OPK 50.29
- Support Level
- KALU $73.91
- OPK $1.34
- Resistance Level
- KALU $77.54
- OPK $1.44
- Average True Range (ATR)
- KALU 1.75
- OPK 0.04
- MACD
- KALU 0.17
- OPK -0.00
- Stochastic Oscillator
- KALU 57.98
- OPK 40.00
About KALU Kaiser Aluminum Corporation
Kaiser Aluminum Corp produces and sells semi-fabricated specialty aluminum products predominantly to industrial customers. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from the United States.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.